We know who control the corporate direction at IMU so it doesn't matter who you replace as CEO. As long as she is manage the clinical trials then her performance has been excellent, did you buy back looking at a trade or ST as you saw how cheap the pps was after it somehow unexpectedly drop below 10c easily after consolidating there for months from the excellent clinical trial update for VAXINIA and then somehow drop even further after the excellent clinical trial update for Azer-Cel and want to blame someone????
IMU Price at posting:
3.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)